What this site covers, and what it does not
FarmaConnect is a technology vendor's website. It explains how a pharmacy can organise itself with tools such as electronic shelf labels, digital signage, integration with the pharmacy management system or queue management. It is not a source of medicines information for patients, a clinical advice service or a law firm.
That sets the limits of what we write:
- We do not give individual clinical advice or recommend specific medicines to the public.
- We do not promise health outcomes, guaranteed sales or "automatic" regulatory compliance from using a product.
- When a page touches regulation, it explains what the rule says and what it means for how a pharmacy operates, not what a particular case must do. That is a question for your own adviser.
The reason for the caution is simple. Google classes as YMYL ("Your Money or Your Life") the topics that can affect people's health or wellbeing, and expects greater accuracy and alignment with expert consensus on them. A pharmacy software site is not medical content, but it sits close to it, and we treat it with the same care.
Who writes and who reviews
Each page shows who signs it, the date of its last update and, once there has been one, who reviewed it.
Writing. For now, pages are signed by the FarmaConnect editorial desk as a team rather than by a named individual. When individual authors sign, their background will be on the team page.
Pharmacist review. Any page that describes a pharmacy process (dispensing, price management, product categories, counter service) has to be read by a registered pharmacist before it counts as reviewed. Their job is to catch descriptions that do not match how a real pharmacy works.
Legal review. Pages that cite regulation, advertising, data protection or the sale of products also go through a person with legal training, who checks that what is cited exists, is in force and is not stretched in its interpretation.
A page that deals with regulation but shows no reviewer on its card has not yet passed this filter. It is a useful reading rule: if the name is missing, be wary. As of this version, no page on the site shows a reviewer yet, this one included.
The names, professional registration numbers and roles of our reviewers will appear on the editorial team profiles. We do not invent them or use generic profiles. A fictitious author, an AI-made portrait or a credential nobody can check misleads the reader, and on a topic this close to health that matters more than anywhere else.
Source policy
The hierarchy, from most to least weight:
| Level | What it is | Examples | Use |
|---|---|---|---|
| 1. Primary | Legal texts and official registers | BOE (Spain's official gazette) and regional gazettes; summaries of product characteristics in CIMA | Cited for any regulatory claim or any claim about a medicine |
| 2. Institutional | Bodies with a recognised role | AEMPS, Ministry of Health, CGCOF | Criteria, announcements and circulars |
| 3. Secondary | Trade press, legal commentary | Industry media, law firms | Supporting material only, and labelled as such |
| 4. Vendor | Manufacturer documentation and websites | Manuals, product data sheets | To describe features; never as proof of compliance |
A few specific rules:
- Every external figure or fact carries a source in the page's sources section, with a link checked on the review date.
- Legislation is cited by its official identifier (for example, Royal Legislative Decree 1/2015, the consolidated text of the Law on guarantees and rational use of medicines and medical devices) and always with the BOE's consolidated version in front of us, not a third-party summary. Most official texts are in Spanish; where we paraphrase them in English, the Spanish original prevails.
- For medicines we point to CIMA, the online medicines information centre of the AEMPS, rather than reproducing indications or dosages.
- Professional bodies such as the General Council of Official Pharmacists' Associations (CGCOF) are used for professional criteria, not as a substitute for the legal text.
- What we cannot verify, we do not assert. If a source does not confirm a fact, it is left out or written as "not stated".
- What we say about Keonex and its products is kept apart from what we say about the sector. A product feature is a commercial claim and is presented as one, not disguised as neutral data.
How we handle advertising and commercial information
This site promotes services. That is no secret, and the methodology says so to stop commercial content passing itself off as informational.
- Product pages are written as product pages. Guides and articles explain, and their calls to action are set apart from the body text.
- We do not publish claims about medicines, their efficacy or their price as if FarmaConnect sold or dispensed them. The site offers technology, not dispensing.
- Online sales of non-prescription medicines are reserved for authorised pharmacies. If a page mentions it, it is to describe the legal framework, not to suggest that FarmaConnect takes part.
- Examples of pharmacies, savings figures or client results appear only with documented consent and a source. Until they exist, they are not shown.
Use of artificial intelligence
We say plainly how it is used, because Google recommends explaining how content was produced when readers might wonder, and because Article 50 of the EU AI Act governs transparency for AI-generated text.
What AI may do here: help find and organise documentation, suggest outlines, spot inconsistencies between pages and check spelling.
What it may not do:
- Decide what a rule says. A person makes that reading from the official text.
- Supply data, quotations or links that have not been checked by hand.
- Publish. Nothing goes out without a full read-through and the responsibility of a person with an editorial role.
- Generate authors, reviewers, testimonials or client case studies.
How it is disclosed. This page is the general disclosure: AI tools are used on this site as an aid when preparing texts. Disclosing it does not replace review: the Act exempts text from disclosure when it has undergone human review or editorial control and a natural or legal person holds editorial responsibility for the publication. Our approach is to disclose anyway and keep that responsibility with a named person.
If the interpretation applying to this kind of site changes, this section will be updated and the change recorded.
Update schedule
Regulation and product change at different speeds, so not everything is reviewed as often.
| Content type | Scheduled review | Extraordinary trigger |
|---|---|---|
| Regulation | Every six months | Publication or amendment of the rule cited |
| Service and product pages | Every six months | Change in features, plans or integrations |
| Guides and articles | Every twelve months | A cited source changes, or a correction is received |
| This methodology | Every twelve months | Change in process, reviewers or AI rules |
Two dates appear on every page: publication and last update. The second changes only when the content really changes, not because a comma was touched.
Corrections
We will get things wrong now and then. What matters is how we fix them.
- Receipt. Any reader can flag an error, naming the page and the statement, through the site contact.
- Verification. We check it against the primary source. If the report is right, we correct it.
- Notice on the page. Changes that alter the meaning of a statement (a figure, a deadline, an obligation) are noted at the foot with the date and what changed. Minor style fixes are not.
- History is not erased. We do not quietly rewrite a wrong statement: we correct it and leave a record.
- Withdrawal. If a page cannot be sustained, it is withdrawn or marked noindex until resolved.
What to expect from each type of page
So readers know what level of checking stands behind it:
- Regulation (example): primary source linked, double review, notice that it is not advice.
- Services and solutions (electronic shelf labels for pharmacies): a commercial description that Keonex has to validate and that, where it affects the counter, also goes through pharmacist review.
- Guides and articles: sources cited, editorial review and, where they touch regulation, legal review.
Limits of this policy
An editorial policy is a commitment, not a guarantee. Review and sources reduce the risk of error but do not remove it. If your decision depends on a regulatory fact, check it against the primary source we link and with your own adviser.
Coming soon.
